Regeneron
Manufacturing · New York, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
777 Old Saw Mill River Rd, Tarrytown, Ne...Phone Number
(914) 847-7000Website
www.regeneron.comRevenue
$15.5 BillionStock Symbol
REGNIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
3
3
2
1
1
About Regeneron
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.Explore more
Regeneron Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Regeneron your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Regeneron has new funding data
Earning: See what the market has to say on Regeneron recently announced quarterly report
Check out if Regeneron is spiking on competitors!
Check if Regeneron has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Regeneron had a recent Job posting/layoffs
Regeneron, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Regeneron launches new products
Congratulate Masked Content for being promoted to Masked Content at Regeneron
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Explore company insights
Get a deeper look into Regeneron's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Regeneron is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Regeneron is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Regeneron.
Regeneron financials insights
Gather financial insights about Regeneron, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1991
Stock Offering
$91.4M
2010
Stock Offering
$174.7M
2011
Debt
$400M
Regeneron Tech Stack
A closer look at the technologies used by Regeneron
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Product Development, Medical Research, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Regeneron News & Media
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Novo Nordisk is bigger and more profitable on paper, but pricing pressure, reduced Medicaid coverage, and intensifying competition are creating headwinds that Regeneron simply does not face right now.Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum
Regeneron Pharmaceuticals (NASDAQ:REGN) outlined growth opportunities for Dupixent, pipeline catalysts for cemdisiran and continued commercial momentum for EYLEA HD during the Morgan Stanley Global Healthcare Conference. Marion McCourt, Regeneron’s EVP and head of commercial, said Dupixent’s growthREGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS LawBronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Regeneron (REGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 9/14/2026
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Regeneron
Sign Up For FreeTo access detailed company insights
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.... Read More
